The minority shares are currently owned by University of Colorado (CU) chemists Lajos Gera and Robert Hodges (the minority shareholders) who have granted the sole and exclusive option
Syndeohealth claims that it continues to bring effective solutions to help physicians to reduce medical errors, make informed clinical decisions for their patients and improve the quality of
SuccessEHS said that its Mobile EHR is a convenient and portable way for physicians to review summary patient data and dictate into SuccessEHS EHR. SuccessEHS said that by
SDIS is a solution that closes a major gap in the nonclinical phase of the R&D lifecycle and also creates an instantly searchable resource of all nonclinical study
Antares claims that its new Vibex QS auto-injector platform offers a dose capacity of 1ml and greater in a compact design. Additionally, the new design also accommodates fast
Pfizer said that Axitinib is an oral and selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2 and 3. Pfizer Oncology Business Unit Clinical Development senior
Of the additional sites, the Stanford Cancer Center (Stanford, California) under principal investigator Jason Gotlib, has already commenced enrolling patients, additionally the company will start recruiting patients in
Ziopharm said that the preclinical work was designed to study darinaparsin’s cytotoxic and radiosensitizing effects against different solid tumor cell lines under both normoxic (NO) and hypoxic (HO)
J&J and Takeda, which co-market Velcade, said the impurities were made of a white polyester like material that stemmed from a filtration system used in the manufacturing process.
Elorac said that in two phase III pivotal double-blind, randomised, vehicle-controlled, paired-comparison, multi-center studies, the results showed reductions in acne lesion counts after 8 and 12 weeks of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.